InvestorsHub Logo
Followers 23
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: Buyfor1sell for2 post# 143553

Tuesday, 06/30/2020 8:00:51 AM

Tuesday, June 30, 2020 8:00:51 AM

Post# of 182970
GALT - Galectin Therapeutics Announces Commencement of patient enrollment of the adaptively-designed Phase 2b/3 trial of Belapectin in NASH Cirrhosis (Stock Price: 3.04)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.